Hiscox (LON:HSX – Get Free Report) had its price target boosted by analysts at JPMorgan Chase & Co. from GBX 1,600 to GBX 1,800 in a report released on Tuesday,Digital Look reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 17.19% from the company’s previous close.
HSX has been the subject of several other research reports. Jefferies Financial Group boosted their target price on Hiscox from GBX 1,068 to GBX 1,148 and gave the stock an “underperform” rating in a research note on Thursday, March 5th. The Goldman Sachs Group boosted their target price on Hiscox from GBX 1,560 to GBX 1,713 and gave the stock a “buy” rating in a research note on Wednesday, January 21st. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Hiscox currently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,516.83.
Read Our Latest Research Report on HSX
Hiscox Stock Performance
About Hiscox
Hiscox is a global, specialty insurer, listed on the London Stock Exchange and headquartered in Bermuda. We have grown from
our roots as a niche Lloyd’s of London underwriter into a diversified international insurance group operating across direct?to?consumer, broker and partner?distributed retail insurance; large and complex commercial insurance; reinsurance and insurance?linked strategies.
We currently employ over 3,000 people worldwide across 13 countries and 31 offices. We have a distinctive brand, energised and ambitious teams, a strong balance sheet, and plenty of room to grow in each of our chosen markets and lines of business.
See Also
Receive News & Ratings for Hiscox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hiscox and related companies with MarketBeat.com's FREE daily email newsletter.
